ROYAL BANK OF CANADA - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 62 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q1 2022$408,000
-0.5%
41,3900.0%0.00%
Q4 2021$410,000
-0.7%
41,390
-0.4%
0.00%
Q3 2021$413,0000.0%41,565
+0.4%
0.00%
Q2 2021$413,000
-4.4%
41,417
-3.3%
0.00%
Q1 2021$432,00042,8420.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
First Trust Capital Management L.P. 210,000$2,098,0000.31%
Arena Capital Advisors, LLC- CA 225,899$2,257,0000.19%
PERISCOPE CAPITAL INC. 465,285$4,648,0000.15%
Wealthspring Capital LLC 54,647$545,0000.14%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$657,0000.08%
Mint Tower Capital Management B.V. 100,000$999,0000.07%
Sage Mountain Advisors LLC 41,340$413,0000.07%
GLAZER CAPITAL, LLC 284,104$2,838,0000.04%
KING STREET CAPITAL MANAGEMENT, L.P. 50,000$500,0000.04%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 30,062$300,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders